GLP Watchdog

Brello Health vs Hers

Hers has an open FDA warning letter dated September 9, 2025. Brello Health has none. No price lines up like for like. They share compounded semaglutide injection, but Brello Health's $157.72 is a 3-month prepaid rate.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Brello Health / Hers

Brello Health logo

Brello Health

8.1/10

Hers logo

Hers

6.8/10

FDA warning letters
None on record
Pharmacy
Lowest standing price
$157.72/moCompounded semaglutide injection, 3-month prepaid plan
$199/moCompounded semaglutide injection
States
40 states and DC
All 50 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked September 2026
Visit Brello Health
Visit Hers

Neither Brello Health nor Hers pays us. Links to them earn nothing. Scores: Brello Health 8.1, Hers 6.8. How we are paid

What the record shows

  1. 01

    Hers has an open FDA warning letter dated September 9, 2025. Brello Health has none.

  2. 02

    Brello Health names SouthEnd Pharmacy, a 503A pharmacy. Hers names three pharmacies.

  3. 03

    No price lines up like for like. They share compounded semaglutide injection, but Brello Health's $157.72 is a 3-month prepaid rate.

  4. 04

    Only Brello Health lists a price for compounded tirzepatide injection. Only Hers lists a price for brand-name tirzepatide pen.

  5. 05

    Hers covers 10 states Brello Health does not.

  6. 06

    Brello Health holds you to a 3-month prepay (6-month plan optional); Hers states you can cancel at any time.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Brello Health

Hers

Compounded semaglutide injection

$157.72/mo

3-month prepaid plan; not compared

$199/mo

$2,388 a year

Compounded tirzepatide injection

$176.69/mo

6-month prepaid plan; not compared

Not sold or not priced
Brand-name tirzepatide pen
Not sold or not priced

$299/mo

medication only, membership extra; not compared

Price includes
Medication, clinician visits
Medication
Billed separately
Not stated
Clinician visits, coaching
Cancel any time
No
Yes, stated
Minimum term
3-month prepay (6-month plan optional)
None
Refunds
Full refund before a prescription; $50 fee within 24 hours after; none once dispensed
No refund guaranteed once the pharmacy has processed an order

Read off each seller’s own pages. Brello Health: October 25, 2026. Hers: September 28, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Brello Health

8.1/10
  • No FDA warning letter on record
  • Sells compounded tirzepatide injection, which Hers does not price
  • Price includes clinician visits
  • Minimum commitment before you can cancel
  • Lowest price is a 3-month prepaid rate
Visit Brello Health

The case for Hers

6.8/10
  • Sells brand-name tirzepatide pen, which Brello Health does not price
  • Lists 50 states against 40
  • States you can cancel at any time
  • Open FDA warning letter, September 9, 2025
  • Price leaves out clinician visits and coaching
Visit Hers

Scores

Brello Health 8.1 · Hers 6.8 out of 10. Six weighted parts.

Value25%

6.0A
vs
B
3.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

10.0A
vs
B
7.0

Accessibility10%

8.4A
vs
B
10.0

Support10%

5.5A
vs
B
3.0

The score is the same formula for every seller. Payment does not enter it. Method

Brello Health vs Hers: questions

Hers has an open FDA warning letter dated September 9, 2025. Brello Health has none. Letters are matched to a seller by company, domain and address, never by a similar name.
Brello Health names SouthEnd Pharmacy, a 503A pharmacy. Hers names three pharmacies. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
No price lines up like for like. They share compounded semaglutide injection, but Brello Health's $157.72 is a 3-month prepaid rate. We only set two prices against each other when they are for the same product and both are standing month-to-month or 4-week rates.
Brello Health has a minimum term (3-month prepay (6-month plan optional)). Hers states you can cancel at any time; refunds: no refund guaranteed once the pharmacy has processed an order.
Neither Brello Health nor Hers pays us. Links to them earn nothing. Scores: Brello Health 8.1, Hers 6.8.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks